| Primary |
| Product Used For Unknown Indication |
34.8% |
| Drug Dependence |
27.7% |
| Drug Use For Unknown Indication |
16.8% |
| Depression |
4.9% |
| Anxiety |
3.6% |
| Pain |
3.3% |
| Hypertension |
2.1% |
| Insomnia |
1.6% |
| Bipolar Disorder |
0.7% |
| Sleep Disorder |
0.7% |
| Asthma |
0.6% |
| Attention Deficit/hyperactivity Disorder |
0.4% |
| Drug Abuse |
0.4% |
| Pain Management |
0.4% |
| Anxiety Disorder |
0.4% |
| Drug Withdrawal Syndrome |
0.4% |
| Migraine |
0.4% |
| Accidental Exposure |
0.3% |
| Dependence |
0.3% |
| Nausea |
0.3% |
|
| Suicidal Ideation |
13.4% |
| Vomiting |
12.5% |
| Convulsion |
7.3% |
| Drug Withdrawal Syndrome |
6.2% |
| Drug Exposure During Pregnancy |
5.4% |
| Death |
5.3% |
| Substance Abuse |
4.6% |
| Drug Withdrawal Syndrome Neonatal |
4.5% |
| Somnolence |
3.9% |
| Withdrawal Syndrome |
3.9% |
| Tremor |
3.5% |
| Maternal Exposure During Pregnancy |
3.4% |
| Pain |
3.4% |
| Foetal Exposure During Pregnancy |
3.3% |
| Insomnia |
3.3% |
| Loss Of Consciousness |
3.3% |
| Suicide Attempt |
3.3% |
| Weight Increased |
3.3% |
| Road Traffic Accident |
3.1% |
| Wrong Technique In Drug Usage Process |
3.0% |
|
| Secondary |
| Drug Dependence |
28.5% |
| Product Used For Unknown Indication |
27.9% |
| Drug Use For Unknown Indication |
11.3% |
| Depression |
7.0% |
| Pain |
6.2% |
| Anxiety |
5.2% |
| Hypertension |
3.3% |
| Insomnia |
1.8% |
| Asthma |
1.0% |
| Sleep Disorder |
0.9% |
| Bipolar Disorder |
0.8% |
| Drug Abuse |
0.8% |
| Foetal Exposure During Pregnancy |
0.8% |
| Pregnancy |
0.8% |
| Attention Deficit/hyperactivity Disorder |
0.7% |
| Migraine |
0.7% |
| Nausea |
0.7% |
| Anxiety Disorder |
0.6% |
| Back Pain |
0.5% |
| Pain Management |
0.5% |
|
| Vomiting |
12.0% |
| Drug Exposure During Pregnancy |
11.0% |
| Suicidal Ideation |
9.7% |
| Weight Increased |
5.7% |
| Substance Abuse |
5.6% |
| Tremor |
5.6% |
| Withdrawal Syndrome |
5.1% |
| Drug Withdrawal Syndrome |
4.4% |
| Pregnancy |
4.4% |
| Wrong Technique In Drug Usage Process |
3.9% |
| Pain |
3.8% |
| Somnolence |
3.8% |
| Insomnia |
3.7% |
| Loss Of Consciousness |
3.7% |
| Convulsion |
3.6% |
| Intentional Drug Misuse |
3.6% |
| Overdose |
2.9% |
| Nausea |
2.8% |
| Pneumonia |
2.5% |
| Oedema Peripheral |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.3% |
| Hepatitis C |
12.7% |
| Pain |
10.1% |
| Depression |
8.5% |
| Anxiety |
5.7% |
| Drug Dependence |
5.4% |
| Bipolar Disorder |
3.3% |
| Crohn's Disease |
3.2% |
| Premenstrual Syndrome |
2.7% |
| Insomnia |
2.5% |
| Abdominal Pain |
2.4% |
| Hiv Infection |
2.3% |
| Contraception |
2.2% |
| Hypertension |
2.2% |
| Drug Use For Unknown Indication |
1.8% |
| Nausea |
1.8% |
| Sleep Disorder |
1.8% |
| Smoking Cessation Therapy |
1.8% |
| Drug Withdrawal Syndrome |
1.7% |
| Gastrooesophageal Reflux Disease |
1.5% |
|
| Vomiting |
10.6% |
| Pain |
8.5% |
| Drug Ineffective |
7.4% |
| Weight Decreased |
7.4% |
| Vision Blurred |
5.3% |
| White Blood Cell Count Decreased |
5.3% |
| Stevens-johnson Syndrome |
4.8% |
| Drug Dependence |
4.3% |
| Drug Screen Positive |
4.3% |
| Paraesthesia |
4.3% |
| Swelling |
4.3% |
| Tremor |
4.3% |
| Weight Increased |
4.3% |
| Anxiety |
3.7% |
| Death |
3.7% |
| Depression |
3.7% |
| Nausea |
3.7% |
| Renal Failure Acute |
3.7% |
| Insomnia |
3.2% |
| Oedema Peripheral |
3.2% |
|
| Interacting |
| Product Used For Unknown Indication |
45.7% |
| Pain |
11.4% |
| Crohn's Disease |
5.7% |
| Depression |
5.7% |
| Drug Use For Unknown Indication |
5.7% |
| Anxiety |
2.9% |
| Bipolar Disorder |
2.9% |
| Colitis Ulcerative |
2.9% |
| Fibromyalgia |
2.9% |
| Gastroenteritis Eosinophilic |
2.9% |
| Myoclonic Epilepsy |
2.9% |
| Myoclonus |
2.9% |
| Post-traumatic Stress Disorder |
2.9% |
| Smoking Cessation Therapy |
2.9% |
|
| Drug Interaction |
50.0% |
| Somnolence |
16.7% |
| Toothache |
16.7% |
| Urinary Retention |
16.7% |
|
